Sign In
Buy SRTS
$2.84
+0 (+0%)
At Close: Jun 03, 2026
Sensus Healthcare GAAP EPS of $0.32 beats by $0.17, revenue of $13.03M beats by $1.96M
09:55pm, Thursday, 10'th Feb 2022 Seeking Alpha
Sensus Healthcare press release (NASDAQ:SRTS): Q4 GAAP EPS of $0.32 beats by $0.17.Revenue of $13.03M (+156.0% Y/Y) beats by $1.96M.Shares +7.25%.
Sensus Healthcare Reports Record Sales and Earnings for the 2021 Fourth Quarter
09:05pm, Thursday, 10'th Feb 2022 GlobeNewswire Inc.
4Q21 diluted EPS of $0.32 on revenues of $13.0 million up 433% and 156%, respectively
Sensus Healthcare Reports Record Sales and Earnings for the 2021 Fourth Quarter
09:05pm, Thursday, 10'th Feb 2022 GlobeNewswire
4Q21 diluted EPS of $0.32 on revenues of $13.0 million up 433% and 156%, respectively
Sensus Healthcare, Inc. (SRTS) Earnings Expected to Grow: Should You Buy?
08:01pm, Thursday, 03'rd Feb 2022 Zacks Investment Research
Sensus Healthcare, Inc. (SRTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com featured highlights include: Sensus Healthcare, Inc., Stride, Inc., Euroseas Ltd. and Vocera Communications, Inc
10:07am, Thursday, 03'rd Feb 2022 Zacks Investment Research
Sensus Healthcare, Inc., Stride, Inc., Euroseas Ltd. and Vocera Communications, Inc are highlighted in this Screen of the Week article.
Buy These 4 Low-Beta Stocks to Sail Through the Choppy Market
10:00am, Wednesday, 02'nd Feb 2022
It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Sensus Healthcare (SRTS), Stride, Inc. (LRN), Euroseas Ltd.
Sensus Healthcare Prepares Organization for Long-term Growth with Three Promotions
09:05pm, Monday, 31'st Jan 2022 GlobeNewswire Inc.
Michael J. Sardano named President, Christopher Machuzak and Jeffrey Starling named Regional Vice Presidents of Sales Michael J. Sardano named President, Christopher Machuzak and Jeffrey Starling name
Sensus Healthcare, Inc. (SRTS) Just Reclaimed the 50-Day Moving Average
03:00pm, Wednesday, 26'th Jan 2022 Zacks Investment Research
Is it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?
Sensus Healthcare to Host Fourth Quarter 2021 Financial Results and Business Update Conference Call on February 10, 2022
01:30pm, Wednesday, 26'th Jan 2022 GlobeNewswire Inc.
BOCA RATON, Fla, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and
Sensus Healthcare, Inc. (SRTS) Just Reclaimed the 50-Day Moving Average
11:31am, Wednesday, 26'th Jan 2022
Is it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?
Sensus Healthcare to Host Fourth Quarter 2021 Financial Results and Business Update Conference Call on February 10, 2022
08:30am, Wednesday, 26'th Jan 2022
BOCA RATON, Fla, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and n
Zacks.com featured highlights include: Metropolitan Bank Holding Corp., Horizon Bancorp Inc., CBIZ Inc., Sensus Healthcare Inc. and Ocwen Financial Corp
11:42am, Thursday, 20'th Jan 2022 Zacks Investment Research
Metropolitan Bank Holding Corp., Horizon Bancorp Inc., CBIZ Inc., Sensus Healthcare Inc. and Ocwen Financial Corp are highlighted in this Screen of the Week article.
5 Stocks With Recent Price Strength in a Volatile January
10:50am, Wednesday, 19'th Jan 2022 Zacks Investment Research
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are MCB, HBNC, SRTS, OCN and CBZ.
5 Stocks With Recent Price Strength in a Volatile January
06:56am, Wednesday, 19'th Jan 2022
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are MCB, HBNC, SRTS, OCN and CBZ.
Bet on These 4 Low-Beta Stocks to Counter Market Volatility
11:56am, Tuesday, 18'th Jan 2022 Zacks Investment Research
It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Sensus Healthcare (SRTS), Toyota Motor (TM), ACM Research (ACMR) and Vocera (VCRA) are well poised to gain.
